Figuring out what the ultimate “Lab 4.0” looks like is a tough task, but to be successful in your digital journey, it is important to focus on your goals as a business, and what suits objectives and your staff most. Different methods will suit different organisations – perhaps certain tasks must remain manual for your scientists to be efficient, while others are in dire need of digitalisation to drive efficiency and save lead time and costs. The question of finding a balance remains: will the lab of the future be fully automated, or is there a risk of creating complexity? Join our round-up panel discussion to hear what lab leaders wish to focus on going forward.

Exploring the challenges and opportunities faced by healthcare startups in translating scientific or technological innovations into market-ready solutions.

• How do startups align their innovations with the needs of healthcare providers, patients, and payers?
• What strategies should startups use to connect with key stakeholders, including physicians, regulatory bodies and investors?
• Highlighting the importance of product commercialisation – how can startups navigate the complexities of market adoption, especially when their products are technically advanced but may be misaligned or undervalued?
• How can startups effectively navigate complex approval processes (e.g., TGA, FDA) and ensure compliance while maintaining agility in their development process?